Target intelligence / Profile preview

Novel transcript, antisense to CXCL6

Molecular classification
Long non-coding RNA, lncRNA
01

Overview

This is a predicted long non-coding RNA gene, annotated as "novel transcript, antisense to CXCL6". It is a non-protein-coding transcript defined based on its genomic position opposite to the CXCL6 gene. There is no published evidence supporting a direct biochemical, regulatory, or disease role, and it is not considered a drug target. Many such non-coding transcripts are identified via high-throughput sequencing and computational annotation pipelines, and most remain functionally uncharacterized. This Ensembl object (ENSG00000298131) should not be confused with the protein-coding chemokine gene CXCL6 (ENSG00000124875), which encodes an inflammatory chemokine (and is a recognized therapeutic target in inflammation, cancer, and infection). The query target here is a different locus—an uncharacterized non-coding transcript, not a canonical drug target gene.

Other names
ENSG00000298131
02

Mechanism of action

None, as it is not a validated target for drug therapy.

03

Biological functions

UnknownNo experimentally validated biological functionsDefined only by its genomic location antisense to CXCL6
04

Disease associations

None reportedNo validated disease association

Beyond the preview

Go deeper on Novel transcript, antisense to CXCL6.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to CXCL6.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call